I was like, it could not be me
Overall, we found no evidence to support clinical evaluation of liraglutide as a potential candidate for the treatment of ALS
Synthetic Peptides Synthetic peptides are lab-engineered to mimic or enhance the effects of their natural counterparts
10.1074/jbc.M111.253039 Summary Keywords stable gastric pentadecapeptide BPC 157, fistula, bleeding disorder, concept practical applicability, wound healing Citation Seiwerth S, Milavic M, Vukojevic J, Gojkovic S, Krezic I, Vuletic LB, Pavlov KH, Petrovic A, Sikiric S, Vranes H, Prtoric A, Zizek H, Durasin T, Dobric I, Staresinic M, Strbe S, Knezevic M, Sola M, Kokot A, Sever M, Lovric E, Skrtic A, Blagaic AB and Sikiric P (2021) Stable Gastric Pentadecapeptide BPC 157 and Wound Healing
All factual claims are supported by cited sources where available
3 86.4% of participants on semaglutide lost at least 5% of their body weight, and 69.1% lost at least 10%